PABPN1 Chromosome 14
Poly(A) binding protein nuclear 1
Upload your DNA to see your personal genotypes for variants in PABPN1.
What This Gene Does
This gene encodes an abundant nuclear protein that binds with high affinity to nascent poly(A) tails. The protein is required for progressive and efficient polymerization of poly(A) tails at the 3' ends of eukaryotic transcripts and controls the size of the poly(A) tail to about 250 nt. At steady-state, this protein is localized in the nucleus whereas a different poly(A) binding protein is localized in the cytoplasm. This gene contains a GCG trinucleotide repeat at the 5' end of the coding region, and expansion of this repeat from the normal 6 copies to 8-13 copies leads to autosomal dominant oculopharyngeal muscular dystrophy (OPMD) disease. Related pseudogenes have been identified on chromosomes 19 and X. Read-through transcription also exists between this gene and the neighboring upstream BCL2-like 2 (BCL2L2) gene. [provided by RefSeq, Dec 2010]
Gene Info
Gene Group
RNA binding motif containing
Locus Type
gene with protein product
Location
14q11.2
Ensembl
ENSG00000100836
Associated Conditions (4)
Oculopharyngeal muscular dystrophy 1
PABPN1-related disorder
Oculopharyngeal muscular dystrophy
Inborn genetic diseases
Key Variants
RS1045060319
Conflicting classifications of pathogenicity
Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1
Health Risk
RS1401656265
Conflicting classifications of pathogenicity
Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1
Health Risk
RS1433496791
Conflicting classifications of pathogenicity
Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1
Health Risk
RS947151586
Conflicting classifications of pathogenicity
PABPN1-related disorder, Oculopharyngeal muscular dystrophy 1, PABPN1-related disorder
Health Risk
RS1337792814
Pathogenic
Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1
Health Risk
RS1888253108
Pathogenic
Health Risk
RS1888255467
Pathogenic
Health Risk
RS193922941
Pathogenic
Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy, Inborn genetic diseases
Health Risk
RS1594987281
Pathogenic/Likely pathogenic
Oculopharyngeal muscular dystrophy, Oculopharyngeal muscular dystrophy
Health Risk
RS1888252890
Pathogenic/Likely pathogenic
Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1
Health Risk
All Variants (10)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS1045060319 | Health Risk | Conflicting classifications of pathogenicity | Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1 |
| RS1401656265 | Health Risk | Conflicting classifications of pathogenicity | Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1 |
| RS1433496791 | Health Risk | Conflicting classifications of pathogenicity | Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1 |
| RS947151586 | Health Risk | Conflicting classifications of pathogenicity | PABPN1-related disorder, Oculopharyngeal muscular dystrophy 1, PABPN1-related disorder |
| RS1337792814 | Health Risk | Pathogenic | Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1 |
| RS1888253108 | Health Risk | Pathogenic | — |
| RS1888255467 | Health Risk | Pathogenic | — |
| RS193922941 | Health Risk | Pathogenic | Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy, Inborn genetic diseases |
| RS1594987281 | Health Risk | Pathogenic/Likely pathogenic | Oculopharyngeal muscular dystrophy, Oculopharyngeal muscular dystrophy |
| RS1888252890 | Health Risk | Pathogenic/Likely pathogenic | Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1 |